These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DuoStim: a new option for fertility preservation for a woman with Turner syndrome. Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708 [TBL] [Abstract][Full Text] [Related]
4. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
5. Optimal timing to retrieve oocytes for fertility preservation in patients with acute myeloid leukemia: two cases of controlled ovarian stimulation using DuoStim with a literature review. Sekiguchi M; Ito A; Fukuda Y; Yoneyama M; Furui M; Nakaoka K; Umemura N; Hayashi Y; Tamaki Y; Katagiri Y; Nakata M Gynecol Endocrinol; 2023 Dec; 39(1):2217262. PubMed ID: 37271166 [TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type. Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618 [TBL] [Abstract][Full Text] [Related]
8. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield. Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808 [TBL] [Abstract][Full Text] [Related]
9. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study. Muteshi C; Child T; Ohuma E; Fatum M Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359 [TBL] [Abstract][Full Text] [Related]
10. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts. Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989 [TBL] [Abstract][Full Text] [Related]
11. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre. Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation. İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878 [TBL] [Abstract][Full Text] [Related]
14. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant. Lavery SA; Islam R; Hunt J; Carby A; Anderson RA Hum Reprod; 2016 Jul; 31(7):1501-7. PubMed ID: 27112701 [TBL] [Abstract][Full Text] [Related]
15. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Talaulikar VS; Conway GS; Pimblett A; Davies MC Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170 [TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls. Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up. Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910 [TBL] [Abstract][Full Text] [Related]
18. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report. Cai H; Shen H Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608 [TBL] [Abstract][Full Text] [Related]
19. Fertility preservation options in breast cancer patients. Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157 [TBL] [Abstract][Full Text] [Related]
20. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age. Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]